US Patent Number
The present invention relates to the use of novel proteins, referred to herein as amidated glial cell line-derived neurotrophic factor (GDNF) peptides (or “Amidated Dopamine Neuron Stimulating peptides (ADNS peptides)”), for treating brain diseases and injuries that result in dopaminergic deficiencies and mitochodrial dysfunction, e.g., reduced complex I enzyme activity.
University of Kentucky Research Foundation, Lexington, KY (US)
Bradley, Luke H.; Gash, Don M.; and Gerhardt, Greg A., "Amidated Dopamine Neuron Stimulating Peptide Restoration of Mitochondrial Activity" (2016). Neuroscience Faculty Patents. 9.